Insider Trading - Dube Eric M

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Dube Eric M

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-01-07
Sale
2020-01-08
8:49 pm
Retrophin Inc. RTRX Dube Eric M
CEO
7,500 $14.54 $109,050 42,500
(Direct)
View
2020-09-18
Sale
2020-09-22
9:15 pm
Retrophin Inc. RTRX Dube Eric M
CEO
10,805 $19.28 $208,319 94,695
(Direct)
View
2021-01-05
Sale
2021-01-07
6:29 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
6,876 $26.83 $184,483 87,819
(Direct)
View
2021-01-31
Sale
2021-02-02
9:20 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
8,734 $29.91 $261,267 151,345
(Direct)
View
2021-02-03
Sale
2021-02-03
9:29 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
2,406 $28.91 $69,557 148,939
(Direct)
View
2021-02-05
Sale
2021-02-09
4:28 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
9,626 $31.5 $303,171 156,813
(Direct)
View
2021-06-01
Sale
2021-06-03
4:07 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
9,562 $14.62 $139,797 147,251
(Direct)
View
2021-08-13
Sale
2021-08-17
7:40 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
7,836 $17.12 $134,142 156,915
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-01-04
Option Award
2019-01-08
5:25 pm
N/A
2029-01-03
Retrophin Inc. RTRX Dube Eric M
CEO
450,000 $0 500,000
(Direct)
View
2019-05-09
Option Award
2019-05-10
9:39 pm
N/A
N/A
Retrophin Inc. RTRX Dube Eric M
CEO
6,000 $0 6,000
(Direct)
View
2020-01-31
Option Award
2020-01-31
8:14 pm
N/A
2030-01-30
Retrophin Inc. RTRX Dube Eric M
CEO
365,000 $0 442,500
(Direct)
View
2020-09-18
Option Award
2020-09-22
9:15 pm
N/A
N/A
Retrophin Inc. RTRX Dube Eric M
CEO
28,000 $0 94,695
(Direct)
View
2021-01-21
Option Award
2021-01-25
8:54 pm
N/A
2031-01-20
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
269,860 $0 357,679
(Direct)
View
2021-01-21(A)
Option Award
2021-01-28
8:00 pm
N/A
2031-01-20
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
212,660 $0 212,660
(Direct)
View
2021-01-31
Option Award
2021-02-02
9:20 pm
N/A
N/A
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
15,000 $0 151,345
(Direct)
View
2021-02-03
Option Award
2021-02-05
4:46 pm
N/A
N/A
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
17,500 $0 166,439
(Direct)
View
2021-08-13
Option Award
2021-08-17
7:40 pm
N/A
N/A
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
17,500 $0 156,915
(Direct)
View
(A) Indicate amendment filing.